FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
马斯克力挺减肥药，Eli Lilly有望上涨近40%
Breen对Eli Lilly给予“跑赢大盘”的评级，并设定了1100美元的目标价，这意味着从周三收盘价来看，股价有38.2%的上涨潜力。Eli Lilly目前在糖尿病药物Mounjaro和减肥药物Zepbound等领域处于领先地位。
Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.
Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength.
The obesity drug race is heating up in more ways than one.Eli Lilly, the world’s biggest pharmaceutical company by market ...
腾讯网11 天
马斯克力挺减肥药，Eli Lilly有望上涨近40%
特朗普宣布将Robert F. Kennedy Jr.任命为领导卫生与公共服务部的候选人后，Eli Lilly也大幅下跌。Kennedy是疫苗的著名怀疑论者，同时也是减肥药物Ozempic ...
Malaysia Sun22 小时
Knockoff versions of Lilly obesity drug must be off shelves: FDA
FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly's blockbuster drugs ...
This Is Huge News for Eli Lilly Investors
Eli Lilly just gave investors several reasons to cheer.
Ozempic MDL Expands to Include New Drugs, but Not New Injuries
"An MDL that encompassed any potential injury relating to use of these exceedingly popular weight loss drugs might quickly ...
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.